Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients
Abstract Background The cerebrospinal fluid (CSF) biomarkers amyloid β (Aβ), phospho tau (P-tau) and total tau (T-tau) are used increasingly to support a clinical diagnosis of Alzheimer’s disease. The diagnostic power of these biomarkers has been reported to vary among different studies’ results. Th...
Main Authors: | Anne-Brita Knapskog, Rannveig Sakshaug Eldholm, Anne Braekhus, Knut Engedal, Ingvild Saltvedt |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | BMC Geriatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12877-017-0611-4 |
Similar Items
-
Association between vascular comorbidity and progression of Alzheimer’s disease: a two-year observational study in Norwegian memory clinics
by: Rannveig Sakshaug Eldholm, et al.
Published: (2018-05-01) -
Correlation between CSF biomarkers of Alzheimer’s disease and global cognition in a psychogeriatric clinic cohort
by: Márcia Radanovic, et al. -
Identifying amyloid pathology–related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study
by: Yuk Yee Leung, et al.
Published: (2015-09-01) -
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
by: Jung Eun Park, et al.
Published: (2019-03-01) -
The meaning of blood and cerebrospinal fluid biomarkers in early diagnosis of Alzheimer's disease
by: Julita Szarpak, et al.
Published: (2020-09-01)